Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.393,60
0,09%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Oncocyte Corporation (OCX) Oncocyte Corporation (OCX) Notizie

OCX

Oncocyte (OCX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OCX
DataOraFonteTitoloSimboloCompagnia
04/06/202423:02Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:OCXOncocyte Corporation
03/06/202420:13GlobeNewswire Inc.Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft StudyNASDAQ:OCXOncocyte Corporation
31/05/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
30/05/202422:47GlobeNewswire Inc.Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of MedicineNASDAQ:OCXOncocyte Corporation
23/05/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OCXOncocyte Corporation
22/05/202423:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCXOncocyte Corporation
17/05/202423:11Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:OCXOncocyte Corporation
15/05/202422:05GlobeNewswire Inc.Oncocyte Reports First Quarter 2024 Financial ResultsNASDAQ:OCXOncocyte Corporation
13/05/202414:00GlobeNewswire Inc.Oncocyte to Announce First Quarter 2024 Financial ResultsNASDAQ:OCXOncocyte Corporation
10/05/202423:31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:OCXOncocyte Corporation
07/05/202415:19GlobeNewswire Inc.PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics MarketplaceNASDAQ:OCXOncocyte Corporation
12/04/202412:00GlobeNewswire Inc.Oncocyte Reports Full Year 2023 Financial ResultsNASDAQ:OCXOncocyte Corporation
12/04/202403:46GlobeNewswire Inc.Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq RulesNASDAQ:OCXOncocyte Corporation
11/04/202423:30GlobeNewswire Inc.Oncocyte and Bio-Rad Partner on Global Launch of Transplant AssayNASDAQ:OCXOncocyte Corporation
09/04/202422:05GlobeNewswire Inc.Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:OCXOncocyte Corporation
16/01/202414:00GlobeNewswire Inc.Oncocyte to Present at the Sequire Investor Summit in Puerto RicoNASDAQ:OCXOncocyte Corporation
06/12/202314:00GlobeNewswire Inc.Oncocyte Begins FDA Submissions Process for VitaGraft Transplant AssaysNASDAQ:OCXOncocyte Corporation
09/11/202323:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OCXOncocyte Corporation
09/11/202313:00GlobeNewswire Inc.Oncocyte Reports Third Quarter 2023 Financial ResultsNASDAQ:OCXOncocyte Corporation
03/11/202313:30GlobeNewswire Inc.Oncocyte to Announce Third Quarter 2023 Financial ResultsNASDAQ:OCXOncocyte Corporation
10/10/202322:48Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:OCXOncocyte Corporation
25/07/202315:08GlobeNewswire Inc.VitaGraft Kidney Expands Utility in Recurrent Primary Disease PatientsNASDAQ:OCXOncocyte Corporation
24/07/202319:35GlobeNewswire Inc.Oncocyte Announces 1-For-20 Reverse Stock SplitNASDAQ:OCXOncocyte Corporation
21/07/202323:16Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:OCXOncocyte Corporation
10/07/202317:20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:OCXOncocyte Corporation
30/06/202322:14Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:OCXOncocyte Corporation
27/06/202314:30GlobeNewswire Inc.Oncocyte Begins Manufacturing Transplant Blood TestNASDAQ:OCXOncocyte Corporation
13/06/202322:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OCXOncocyte Corporation
09/06/202312:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OCXOncocyte Corporation
19/05/202322:52Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OCXOncocyte Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OCX

La tua Cronologia

LSE
RS66
Snb Fund 25
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network